PCRX insider transactions
Pacira BioSciences Inc. (PCRX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for PCRX
- Chief Financial Officer Cross Shawn exercised 12,941 shares at a strike of $16.45 and sold $325,596 worth of shares (12,941 units at $25.16) as part of a pre-agreed trading plan (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- SEC Form 4 filed by Cross Shawn4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Amendment: SEC Form 4 filed by Kronenfeld Mark A.4/A - Pacira BioSciences, Inc. (0001396814) (Issuer)
- SEC Form 4 filed by Slonin Jonathan4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- SEC Form 4 filed by Froimson Mark4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Administrative Officer Williams Kristen was granted 54,546 shares, increasing direct ownership by 42% to 185,849 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Financial Officer Cross Shawn was granted 49,091 shares, increasing direct ownership by 87% to 105,341 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Senior Vice President, Finance Riker Lauren was granted 19,273 shares, increasing direct ownership by 37% to 71,586 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Commercial Officer Teehan Brendan was granted 51,714 shares, increasing direct ownership by 105% to 100,934 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Medical Officer Slonin Jonathan was granted 54,546 shares, increasing direct ownership by 32% to 226,901 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Executive Officer Lee Frank D. was granted 261,818 shares, increasing direct ownership by 66% to 660,831 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Senior Vice President, Finance Riker Lauren covered exercise/tax liability with 2,751 shares and sold $83,240 worth of shares (4,000 units at $20.81), decreasing direct ownership by 11% to 52,313 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Administrative Officer Williams Kristen covered exercise/tax liability with 17,134 shares and sold $269,703 worth of shares (13,137 units at $20.53), decreasing direct ownership by 19% to 131,303 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Commercial Officer Teehan Brendan covered exercise/tax liability with 5,182 shares, decreasing direct ownership by 10% to 49,220 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Medical Officer Slonin Jonathan covered exercise/tax liability with 6,168 shares, decreasing direct ownership by 3% to 172,355 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Executive Officer Lee Frank D. covered exercise/tax liability with 41,488 shares, decreasing direct ownership by 9% to 399,013 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- SEC Form 4 filed by Director Hirawat Samit4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- SEC Form 3 filed by new insider Hirawat Samit3 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Medical Officer Slonin Jonathan covered exercise/tax liability with 381 shares, decreasing direct ownership by 0.21% to 178,523 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Senior Vice President, Finance Riker Lauren covered exercise/tax liability with 159 shares and sold $34,324 worth of shares (1,416 units at $24.24), decreasing direct ownership by 3% to 59,064 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Executive Officer Lee Frank D. covered exercise/tax liability with 9,272 shares, decreasing direct ownership by 2% to 440,501 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Commercial Officer Teehan Brendan was granted 402 shares, increasing direct ownership by 0.74% to 54,402 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Financial Officer Cross Shawn exercised 25,000 shares at a strike of $16.45 and sold $626,751 worth of shares (25,000 units at $25.07) (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Medical Officer Slonin Jonathan sold $95,396 worth of shares (3,960 units at $24.09), decreasing direct ownership by 2% to 178,367 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Financial Officer Cross Shawn sold $266,405 worth of shares (12,060 units at $22.09), decreasing direct ownership by 18% to 56,250 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Financial Officer Cross Shawn covered exercise/tax liability with 6,690 shares, decreasing direct ownership by 9% to 68,310 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Director Ceesay Abraham sold $64,005 worth of shares (2,354 units at $27.19), decreasing direct ownership by 21% to 9,039 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Director Bigal Marcelo sold $116,267 worth of shares (4,912 units at $23.67), decreasing direct ownership by 30% to 11,393 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Medical Officer Slonin Jonathan covered exercise/tax liability with 315 shares, decreasing direct ownership by 0.17% to 182,327 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Director Kronenfeld Mark A. was granted 9,999 shares, increasing direct ownership by 40% to 34,901 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Director Ceesay Abraham was granted 6,163 shares, increasing direct ownership by 118% to 11,393 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Director Froimson Mark was granted 6,163 shares, increasing direct ownership by 43% to 20,636 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Director Bigal Marcelo was granted 6,163 shares, increasing direct ownership by 61% to 16,305 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Director Yang Michael J. was granted 6,163 shares, increasing direct ownership by 85% to 13,393 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Director Christie Christopher was granted 6,163 shares, increasing direct ownership by 59% to 16,654 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Director Young Alethia was granted 6,163 shares, increasing direct ownership by 118% to 11,393 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Director Brege Laura was granted 6,163 shares, increasing direct ownership by 35% to 23,715 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Senior Vice President, Finance Riker Lauren sold $146,208 worth of shares (5,578 units at $26.21) and covered exercise/tax liability with 3,374 shares, decreasing direct ownership by 13% to 59,564 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Administrative Officer Williams Kristen covered exercise/tax liability with 6,162 shares and sold $377,226 worth of shares (14,376 units at $26.24), decreasing direct ownership by 11% to 161,574 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Medical Officer Slonin Jonathan covered exercise/tax liability with 5,084 shares, decreasing direct ownership by 3% to 181,960 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Medical Officer Slonin Jonathan was granted 93,600 shares, increasing direct ownership by 100% to 187,044 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Administrative Officer Williams Kristen was granted 79,200 shares, increasing direct ownership by 77% to 182,112 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Executive Officer Lee Frank D. was granted 350,000 shares, increasing direct ownership by 356% to 448,409 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Commercial Officer Teehan Brendan was granted 54,000 shares (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Senior Vice President, Finance Riker Lauren was granted 30,600 shares, increasing direct ownership by 81% to 68,516 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- SEC Form 3 filed by new insider Teehan Brendan3 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Executive Officer Lee Frank D. covered exercise/tax liability with 9,375 shares, decreasing direct ownership by 9% to 98,409 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Medical Officer Slonin Jonathan covered exercise/tax liability with 371 shares and sold $16,174 worth of shares (879 units at $18.40), decreasing direct ownership by 1% to 93,444 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Operating Officer Gaugler Daryl was granted 244 shares, increasing direct ownership by 0.21% to 115,443 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Senior Vice President, Finance Riker Lauren covered exercise/tax liability with 159 shares, decreasing direct ownership by 0.42% to 37,916 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Operating Officer Gaugler Daryl sold $9,880 worth of shares (500 units at $19.76), decreasing direct ownership by 0.43% to 115,200 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Financial Officer Cross Shawn was granted 75,000 shares (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- SEC Form 3 filed by new insider Cross Shawn3 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Operating Officer Gaugler Daryl sold $6,430 worth of shares (500 units at $12.86), decreasing direct ownership by 0.43% to 115,700 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Director Bigal Marcelo bought $20,034 worth of shares (1,512 units at $13.25), increasing direct ownership by 18% to 10,142 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Director Brege Laura bought $12,810 worth of shares (1,000 units at $12.81), increasing direct ownership by 6% to 17,552 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Director Yang Michael J. bought $25,800 worth of shares (2,000 units at $12.90), increasing direct ownership by 38% to 7,230 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Chief Executive Officer Lee Frank D. bought $99,994 worth of shares (8,264 units at $12.10), increasing direct ownership by 8% to 107,784 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Amendment: Director Bigal Marcelo bought $40,834 worth of shares (3,400 units at $12.01), increasing direct ownership by 65% to 8,630 units (SEC Form 4)4/A - Pacira BioSciences, Inc. (0001396814) (Issuer)
- Director Bigal Marcelo bought $40,834 worth of shares (3,400 units at $12.01), increasing direct ownership by 65% to 8,630 units (SEC Form 4)4 - Pacira BioSciences, Inc. (0001396814) (Issuer)